Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 3/2015

01.12.2015

T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review

verfasst von: Isabel Almeida, Sara Vieira Silva, Ana Raquel Fonseca, Ivone Silva, Carlos Vasconcelos, Margarida Lima

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Scleroderma (SSc) is a rare and heterogeneous immune-mediated disease involving the connective tissue and microvasculature whose pathogenesis remains unclear. Data concerning T and natural killer (NK) cell abnormalities and cytokine levels in the peripheral blood (PB) from patients with SSc are scarce, and the results are contradictory. The present study aimed to analyze the changes of T lymphocytes, NK cells, and T helper (Th)-related cytokines in the PB of patients with SSc in comparison to healthy individuals and its relation to disease subtype and stage, organ involvement, and nailfold capillaroscopic changes. A non-random convenience sample of 57 scleroderma patients was utilized. Fifty-five out of the 57 patients studied were women (97 %); 10 patients presented pre-scleroderma (pre-SSc) and 47 SSc: 34 limited cutaneous SSc (lcSSc) and 13 diffuse cutaneous SSc (dcSSc). Patients with SSc were classified in early (n = 7), intermediate (n = 10), and late (n = 30) disease. Blood samples were analyzed by flow cytometry for total T cells, CD4+ and CD8+ T cell subsets, total NK cells, and CD56+low and CD56+high NK cell subsets. T cells were further analyzed for the expression of the CD56 adhesion molecule and activation-related markers (HLA-DR, CD45RO). In addition, the serum levels of Th1-, Th2-, and Th17-related cytokines were measured by flow cytometry. Twenty-five healthy individuals recruited from the blood bank were used as controls. Patients had lower numbers of total lymphocytes and T cells comparing to healthy controls. Both CD4+ and CD8+ T cells were decreased, but differences were statistically significant only for CD8+ and CD8+ CD45RO+ T cells. These alterations were seen in patients with SSc but not in patients with pre-SSc, and, in general, they were more pronounced in patients with dcSSc than in patients with lcSSc, in patients with vascular involvement than in those without, as well as in patients having active and late nailfold capillaroscopic patterns. CD56+ T cells were also decreased in SSc patients, especially in those with active/late capillaroscopic patterns or with severe lung disease. Diminished numbers of circulating NK cells were also observed in patients with lcSSc and in those with early disease. No statistically significant changes were found in serum cytokine levels, as compared with controls. Patients with SSc had major alterations in circulating CD8+ and CD56+ T cells, as well as in NK cells, suggesting that these cells may play a relevant role in SSc pathogenesis, probably operating at different phases and/or at different organs. In addition, the serum levels of Th1, Th2, and Th17 cytokines did not provide useful information for evaluating T cell polarization in SSc.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
11.
Zurück zum Zitat Scharffetter K, Lankat-Buttgereit B, Krieg T (1988) Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Investig 18:9–17CrossRef Scharffetter K, Lankat-Buttgereit B, Krieg T (1988) Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Investig 18:9–17CrossRef
14.
Zurück zum Zitat Boin F, Rosen A (2007) Autoimmunity in systemic sclerosis: current concepts. Curr Rheumatol Rep 9:165–172PubMedCrossRef Boin F, Rosen A (2007) Autoimmunity in systemic sclerosis: current concepts. Curr Rheumatol Rep 9:165–172PubMedCrossRef
19.
Zurück zum Zitat Arnett FC (2006) Is scleroderma an autoantibody mediated disease? Curr Opin Rheumatol 18:579–581PubMedCrossRef Arnett FC (2006) Is scleroderma an autoantibody mediated disease? Curr Opin Rheumatol 18:579–581PubMedCrossRef
20.
Zurück zum Zitat Sato S, Fujimoto M, Hasegawa M, Takehara K (2004) Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 50:1918–1927. doi:10.1002/art.20274 PubMedCrossRef Sato S, Fujimoto M, Hasegawa M, Takehara K (2004) Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 50:1918–1927. doi:10.​1002/​art.​20274 PubMedCrossRef
21.
22.
Zurück zum Zitat Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354:2667–2676. doi:10.1056/NEJMoa052955 PubMedCrossRef Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354:2667–2676. doi:10.​1056/​NEJMoa052955 PubMedCrossRef
23.
Zurück zum Zitat Francois A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G, Gottenberg J-E (2013) B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthitis Res Ther 15:R168. doi:10.1186/ar4352 CrossRef Francois A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G, Gottenberg J-E (2013) B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthitis Res Ther 15:R168. doi:10.​1186/​ar4352 CrossRef
24.
Zurück zum Zitat Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K (2003) Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Investig Dermatol 120:542–547PubMedCrossRef Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K (2003) Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Investig Dermatol 120:542–547PubMedCrossRef
25.
Zurück zum Zitat Roumm AD, Whiteside TL, Medsger TA, Rodnan GP (1984) Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 27:645–653PubMedCrossRef Roumm AD, Whiteside TL, Medsger TA, Rodnan GP (1984) Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 27:645–653PubMedCrossRef
26.
Zurück zum Zitat Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P (1992) Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 166:255–263PubMedCrossRef Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P (1992) Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 166:255–263PubMedCrossRef
28.
Zurück zum Zitat Whiteside TL, Buckingham RB, Prince RK, Rodnan GP (1984) Products of activated mononuclear cells modulate accumulation of collagen by normal dermal and scleroderma fibroblasts in culture. J Lab Clin Med 104:355–369PubMed Whiteside TL, Buckingham RB, Prince RK, Rodnan GP (1984) Products of activated mononuclear cells modulate accumulation of collagen by normal dermal and scleroderma fibroblasts in culture. J Lab Clin Med 104:355–369PubMed
29.
Zurück zum Zitat Fleischmajer R, Perlish JS, Reeves JR (1977) Cellular infiltrates in scleroderma skin. Arthritis Rheum 20:975–984PubMedCrossRef Fleischmajer R, Perlish JS, Reeves JR (1977) Cellular infiltrates in scleroderma skin. Arthritis Rheum 20:975–984PubMedCrossRef
30.
Zurück zum Zitat Hussein MR, Hassan HI, Hofny ERM, Elkholy M, Fatehy NA, Abd Elmoniem AEA, Ezz El-Din AM, Afifi OA, Rashed HG (2005) Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis. J Clin Pathol 58:178–184. doi:10.1136/jcp.2004.019224 PubMedCentralPubMedCrossRef Hussein MR, Hassan HI, Hofny ERM, Elkholy M, Fatehy NA, Abd Elmoniem AEA, Ezz El-Din AM, Afifi OA, Rashed HG (2005) Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis. J Clin Pathol 58:178–184. doi:10.​1136/​jcp.​2004.​019224 PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Fuschiotti P, Larregina AT, Ho J, Feghali-Bostwick C, Medsger TA (2013) Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum 65:236–246PubMedCentralPubMedCrossRef Fuschiotti P, Larregina AT, Ho J, Feghali-Bostwick C, Medsger TA (2013) Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum 65:236–246PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G (1998) Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum 41:327–334. doi:10.1002/art.37706 PubMedCrossRef Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G (1998) Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum 41:327–334. doi:10.​1002/​art.​37706 PubMedCrossRef
35.
Zurück zum Zitat Riccieri V, Parisi G, Spadaro A, Scrivo R, Barone F, Moretti T, Bernardini G, Strom R, Taccari E, Valesini G (2005) Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis. J Rheumatol 32:283–286PubMed Riccieri V, Parisi G, Spadaro A, Scrivo R, Barone F, Moretti T, Bernardini G, Strom R, Taccari E, Valesini G (2005) Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis. J Rheumatol 32:283–286PubMed
36.
Zurück zum Zitat Giovannetti A, Rosato E, Renzi C, Maselli A, Gambardella L, Giammarioli AM, Palange P, Paoletti P, Pisarri S, Salsano F, Malorni W, Pierdominici M (2010) Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes. Clin Immunol 137:122–133. doi:10.1016/j.clim.2010.06.004 PubMedCrossRef Giovannetti A, Rosato E, Renzi C, Maselli A, Gambardella L, Giammarioli AM, Palange P, Paoletti P, Pisarri S, Salsano F, Malorni W, Pierdominici M (2010) Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes. Clin Immunol 137:122–133. doi:10.​1016/​j.​clim.​2010.​06.​004 PubMedCrossRef
37.
Zurück zum Zitat Radstake TRDJ, van Bon L, Broen J, Wenink M, Santegoets K, Deng Y, Hussaini A, Simms R, Cruikshank WW, Lafyatis R (2009) Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS One 4, e5981. doi:10.1371/journal.pone.0005981 PubMedCentralPubMedCrossRef Radstake TRDJ, van Bon L, Broen J, Wenink M, Santegoets K, Deng Y, Hussaini A, Simms R, Cruikshank WW, Lafyatis R (2009) Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS One 4, e5981. doi:10.​1371/​journal.​pone.​0005981 PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Wells AU, Lorimer S, Majumdar S, Harrison NK, Corrin B, Black CM, Jeffery PK, du Bois RM (1995) Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Eur Respir J 8:266–271PubMedCrossRef Wells AU, Lorimer S, Majumdar S, Harrison NK, Corrin B, Black CM, Jeffery PK, du Bois RM (1995) Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Eur Respir J 8:266–271PubMedCrossRef
39.
Zurück zum Zitat Domagała-Kulawik J, Hoser G, Doboszyńska A, Kawiak J, Droszcz W (1998) Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment. Respir Med 92:1295–1301PubMedCrossRef Domagała-Kulawik J, Hoser G, Doboszyńska A, Kawiak J, Droszcz W (1998) Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment. Respir Med 92:1295–1301PubMedCrossRef
40.
Zurück zum Zitat Yurovsky VV, Wigley FM, Wise RA, White B (1996) Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis. Hum Immunol 48:84–97PubMedCrossRef Yurovsky VV, Wigley FM, Wise RA, White B (1996) Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis. Hum Immunol 48:84–97PubMedCrossRef
43.
Zurück zum Zitat Gorla R, Airò P, Malagoli A, Carella G, Prati E, Brugnoni D, Franceschini F, Cattaneo R (1994) CD4+ and CD8+ subsets: naive and memory cells in the peripheral blood of patients with systemic sclerosis. Clin Rheumatol 13:83–87PubMedCrossRef Gorla R, Airò P, Malagoli A, Carella G, Prati E, Brugnoni D, Franceschini F, Cattaneo R (1994) CD4+ and CD8+ subsets: naive and memory cells in the peripheral blood of patients with systemic sclerosis. Clin Rheumatol 13:83–87PubMedCrossRef
44.
Zurück zum Zitat Fiocco U, Rosada M, Cozzi L, Ortolani C, De Silvestro G, Ruffatti A, Cozzi E, Gallo C, Todesco S (1993) Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity. Ann Rheum Dis 52:272–277PubMedCentralPubMedCrossRef Fiocco U, Rosada M, Cozzi L, Ortolani C, De Silvestro G, Ruffatti A, Cozzi E, Gallo C, Todesco S (1993) Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity. Ann Rheum Dis 52:272–277PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Ercole LP, Malvezzi M, Boaretti AC, Utiyama SR, Rachid A (2003) Analysis of lymphocyte subpopulations in systemic sclerosis. J Investig Allergol Clin Immunol 13:87–93PubMed Ercole LP, Malvezzi M, Boaretti AC, Utiyama SR, Rachid A (2003) Analysis of lymphocyte subpopulations in systemic sclerosis. J Investig Allergol Clin Immunol 13:87–93PubMed
46.
Zurück zum Zitat Fuschiotti P, Medsger TA, Morel PA (2009) Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum 60:1119–1128. doi:10.1002/art.24432 PubMedCrossRef Fuschiotti P, Medsger TA, Morel PA (2009) Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum 60:1119–1128. doi:10.​1002/​art.​24432 PubMedCrossRef
50.
Zurück zum Zitat Horikawa M, Hasegawa M, Komura K, Hayakawa I, Yanaba K, Matsushita T, Takehara K, Sato S (2005) Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity. J Investig Dermatol 125:731–737. doi:10.1111/j.0022-202X.2005.23767 PubMedCrossRef Horikawa M, Hasegawa M, Komura K, Hayakawa I, Yanaba K, Matsushita T, Takehara K, Sato S (2005) Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity. J Investig Dermatol 125:731–737. doi:10.​1111/​j.​0022-202X.​2005.​23767 PubMedCrossRef
51.
Zurück zum Zitat López-Cacho JM, Gallardo S, Posada M, Aguerri M, Calzada D, Mayayo T, González-Rodríguez ML, Rabasco AM, Lahoz C, Cárdaba B (2014) Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease. BioMed Res Int 2014:148293. doi:10.1155/2014/148293 PubMedCentralPubMedCrossRef López-Cacho JM, Gallardo S, Posada M, Aguerri M, Calzada D, Mayayo T, González-Rodríguez ML, Rabasco AM, Lahoz C, Cárdaba B (2014) Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease. BioMed Res Int 2014:148293. doi:10.​1155/​2014/​148293 PubMedCentralPubMedCrossRef
52.
Zurück zum Zitat Wanchu A, Singh VK, Yadav VS, Biswas S, Misra R, Agarwal SS (1995) Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis. Pathobiol J Immunopathol Mol Cell Biol 63:288–292CrossRef Wanchu A, Singh VK, Yadav VS, Biswas S, Misra R, Agarwal SS (1995) Lack of natural killer cell augmentation in vitro by human interferon gamma in a subset of patients with systemic sclerosis. Pathobiol J Immunopathol Mol Cell Biol 63:288–292CrossRef
53.
Zurück zum Zitat Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE, Witte T (2004) Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 50:1561–1565. doi:10.1002/art.20216 PubMedCrossRef Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE, Witte T (2004) Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 50:1561–1565. doi:10.​1002/​art.​20216 PubMedCrossRef
59.
Zurück zum Zitat Parel Y, Aurrand-Lions M, Scheja A, Dayer J-M, Roosnek E, Chizzolini C (2007) Presence of CD4 + CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum 56:3459–3467. doi:10.1002/art.22927 PubMedCrossRef Parel Y, Aurrand-Lions M, Scheja A, Dayer J-M, Roosnek E, Chizzolini C (2007) Presence of CD4 + CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum 56:3459–3467. doi:10.​1002/​art.​22927 PubMedCrossRef
60.
Zurück zum Zitat Atamas SP, Yurovsky VV, Wise R, Wigley FM, Goter Robinson CJ, Henry P, Alms WJ, White B (1999) Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 42:1168–1178PubMedCrossRef Atamas SP, Yurovsky VV, Wise R, Wigley FM, Goter Robinson CJ, Henry P, Alms WJ, White B (1999) Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 42:1168–1178PubMedCrossRef
61.
Zurück zum Zitat Medsger TA, Ivanco DE, Kardava L, Morel PA, Lucas MR, Fuschiotti P (2011) GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production. Arthritis Rheum 63:1738–1747. doi:10.1002/art.30489 PubMedCrossRef Medsger TA, Ivanco DE, Kardava L, Morel PA, Lucas MR, Fuschiotti P (2011) GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production. Arthritis Rheum 63:1738–1747. doi:10.​1002/​art.​30489 PubMedCrossRef
63.
Zurück zum Zitat Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 188:3573–3583. doi:10.4049/jimmunol.1100591 PubMedCrossRef Nakashima T, Jinnin M, Yamane K, Honda N, Kajihara I, Makino T, Masuguchi S, Fukushima S, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H (2012) Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 188:3573–3583. doi:10.​4049/​jimmunol.​1100591 PubMedCrossRef
64.
Zurück zum Zitat Brembilla NC, Montanari E, Truchetet M-E, Raschi E, Meroni P, Chizzolini C (2013) Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts. Arthritis Res Ther 15:R151. doi:10.1186/ar4334 PubMedCentralPubMedCrossRef Brembilla NC, Montanari E, Truchetet M-E, Raschi E, Meroni P, Chizzolini C (2013) Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts. Arthritis Res Ther 15:R151. doi:10.​1186/​ar4334 PubMedCentralPubMedCrossRef
65.
Zurück zum Zitat Truchetet M-E, Brembilla NC, Montanari E, Allanore Y, Chizzolini C (2011) Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 13:R166. doi:10.1186/ar3486 PubMedCentralPubMedCrossRef Truchetet M-E, Brembilla NC, Montanari E, Allanore Y, Chizzolini C (2011) Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 13:R166. doi:10.​1186/​ar3486 PubMedCentralPubMedCrossRef
66.
Zurück zum Zitat Radstake TRDJ, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, Deng Y, Simms R, Lubberts E, Lafyatis R (2009) The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 4, e5903. doi:10.1371/journal.pone.0005903 PubMedCentralPubMedCrossRef Radstake TRDJ, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, Deng Y, Simms R, Lubberts E, Lafyatis R (2009) The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 4, e5903. doi:10.​1371/​journal.​pone.​0005903 PubMedCentralPubMedCrossRef
67.
Zurück zum Zitat Fenoglio D, Battaglia F, Parodi A, Stringara S, Negrini S, Panico N, Rizzi M, Kalli F, Conteduca G, Ghio M, De Palma R, Indiveri F, Filaci G (2011) Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clin Immunol Orlando Fla 139:249–257. doi:10.1016/j.clim.2011.01.013 CrossRef Fenoglio D, Battaglia F, Parodi A, Stringara S, Negrini S, Panico N, Rizzi M, Kalli F, Conteduca G, Ghio M, De Palma R, Indiveri F, Filaci G (2011) Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clin Immunol Orlando Fla 139:249–257. doi:10.​1016/​j.​clim.​2011.​01.​013 CrossRef
70.
Zurück zum Zitat Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, Feghali-Bostwick CA (2011) Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum 63:783–794. doi:10.1002/art.30159 PubMedCentralPubMedCrossRef Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, Feghali-Bostwick CA (2011) Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum 63:783–794. doi:10.​1002/​art.​30159 PubMedCentralPubMedCrossRef
71.
Zurück zum Zitat Truchetet M-E, Brembilla N-C, Montanari E, Lonati P, Raschi E, Zeni S, Fontao L, Meroni P-L, Chizzolini C (2013) Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum 65:1347–1356PubMedCrossRef Truchetet M-E, Brembilla N-C, Montanari E, Lonati P, Raschi E, Zeni S, Fontao L, Meroni P-L, Chizzolini C (2013) Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum 65:1347–1356PubMedCrossRef
72.
73.
Zurück zum Zitat Gourh P, Arnett FC, Assassi S, Tan FK, Huang M, Diekman L, Mayes MD, Reveille JD, Agarwal SK (2009) Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther 11:R147. doi:10.1186/ar2821 PubMedCentralPubMedCrossRef Gourh P, Arnett FC, Assassi S, Tan FK, Huang M, Diekman L, Mayes MD, Reveille JD, Agarwal SK (2009) Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther 11:R147. doi:10.​1186/​ar2821 PubMedCentralPubMedCrossRef
74.
Zurück zum Zitat Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef
75.
Zurück zum Zitat van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747. doi:10.1002/art.38098 PubMedCentralPubMedCrossRef van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747. doi:10.​1002/​art.​38098 PubMedCentralPubMedCrossRef
76.
Zurück zum Zitat LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatology 15:202–205 LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatology 15:202–205
77.
Zurück zum Zitat LeRoy EC, Medsger TA (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
78.
Zurück zum Zitat Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, Miniati I, Tarner IH, Randone SB, Cutolo M, Allanore Y, Distler O, Valentini G, Czirjak L, Müller-Ladner U, Furst DE, Tyndall A, Matucci-Cerinic M, EUSTAR Group (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 70:476–481. doi:10.1136/ard.2010.136929 PubMedCrossRef Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, Miniati I, Tarner IH, Randone SB, Cutolo M, Allanore Y, Distler O, Valentini G, Czirjak L, Müller-Ladner U, Furst DE, Tyndall A, Matucci-Cerinic M, EUSTAR Group (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 70:476–481. doi:10.​1136/​ard.​2010.​136929 PubMedCrossRef
79.
Zurück zum Zitat Fine LG, Denton CP, Korn J, de Crombrugghe B, Black CM (1996) Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy. Lancet 347:1453–1458CrossRef Fine LG, Denton CP, Korn J, de Crombrugghe B, Black CM (1996) Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy. Lancet 347:1453–1458CrossRef
80.
Zurück zum Zitat Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet J-R, Rich E, Grodzicky T, Raymond Y, Senécal J-L (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 58:3902–3912. doi:10.1002/art.24038 PubMedCrossRef Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet J-R, Rich E, Grodzicky T, Raymond Y, Senécal J-L (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 58:3902–3912. doi:10.​1002/​art.​24038 PubMedCrossRef
81.
Zurück zum Zitat Medsger TA Jr, Steen VD (1996) Classification, prognosis. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 51–79 Medsger TA Jr, Steen VD (1996) Classification, prognosis. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 51–79
82.
Zurück zum Zitat Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Choquette D, Raymond Y, Senécal JL (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736PubMedCrossRef Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Choquette D, Raymond Y, Senécal JL (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736PubMedCrossRef
83.
Zurück zum Zitat Medsger TA, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MI, Jimenez SA, Krieg T, Leroy EC, Maddison PJ, Russell ML, Schachter RK, Wollheim FA, Zacharaie H (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167PubMed Medsger TA, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MI, Jimenez SA, Krieg T, Leroy EC, Maddison PJ, Russell ML, Schachter RK, Wollheim FA, Zacharaie H (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167PubMed
84.
Zurück zum Zitat Medsger TA, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(Suppl 29):S42–S46PubMed Medsger TA, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(Suppl 29):S42–S46PubMed
86.
Zurück zum Zitat Lima M, Teixeira MA, Queirós ML, Leite M, Santos AH, Justiça B, Orfão A (2001) Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol Dis 27:731–743PubMedCrossRef Lima M, Teixeira MA, Queirós ML, Leite M, Santos AH, Justiça B, Orfão A (2001) Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol Dis 27:731–743PubMedCrossRef
87.
Zurück zum Zitat Kelly-Rogers J, Madrigal-Estebas L, O'Connor T, Doherty DG (2006) Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro. Hum Immunol 67:863–873PubMedCrossRef Kelly-Rogers J, Madrigal-Estebas L, O'Connor T, Doherty DG (2006) Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro. Hum Immunol 67:863–873PubMedCrossRef
88.
Zurück zum Zitat Ko HS, Fu SM, Wincheste R Jr, Yu DT, Kunkel HG (1979) Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med 150:246–255PubMedCrossRef Ko HS, Fu SM, Wincheste R Jr, Yu DT, Kunkel HG (1979) Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med 150:246–255PubMedCrossRef
89.
Zurück zum Zitat Kristensson K, Dohlsten M, Fischer H, Ericsson PO, Hedlund G, Sjögren HO, Carlsson R (1990) Phenotypical and functional differentiation of CD4+ CD45RA+ human T cells following polyclonal activation. Scand J Immunol 32:243–253PubMedCrossRef Kristensson K, Dohlsten M, Fischer H, Ericsson PO, Hedlund G, Sjögren HO, Carlsson R (1990) Phenotypical and functional differentiation of CD4+ CD45RA+ human T cells following polyclonal activation. Scand J Immunol 32:243–253PubMedCrossRef
90.
Zurück zum Zitat Merkenschlager M, Beverley PC (1989) Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTLp selectively express CD45RO (UCHL1). Int Immunol 1:450–459PubMedCrossRef Merkenschlager M, Beverley PC (1989) Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTLp selectively express CD45RO (UCHL1). Int Immunol 1:450–459PubMedCrossRef
91.
Zurück zum Zitat Wetzig T, Petri JB, Mittag M, Haustein UF (1998) Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis. Arch Dermatol Res 290:187–190PubMedCrossRef Wetzig T, Petri JB, Mittag M, Haustein UF (1998) Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis. Arch Dermatol Res 290:187–190PubMedCrossRef
92.
Zurück zum Zitat Majone F, Olivieri S, Cozzi F, Montaldi A, Tonello M, Visentin MS, Ciprian L, Ruffatti A (2009) Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis. Rheumatol Int 29:891–895. doi:10.1007/s00296-008-0799-x PubMedCrossRef Majone F, Olivieri S, Cozzi F, Montaldi A, Tonello M, Visentin MS, Ciprian L, Ruffatti A (2009) Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis. Rheumatol Int 29:891–895. doi:10.​1007/​s00296-008-0799-x PubMedCrossRef
93.
Zurück zum Zitat Kessel A, Rosner I, Rozenbaum M, Zisman D, Sagiv A, Shmuel Z, Sabo E, Toubi E (2004) Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B. J Clin Immunol 24:30–36PubMedCrossRef Kessel A, Rosner I, Rozenbaum M, Zisman D, Sagiv A, Shmuel Z, Sabo E, Toubi E (2004) Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B. J Clin Immunol 24:30–36PubMedCrossRef
95.
Zurück zum Zitat Degiannis D, Seibold JR, Czarnecki M, Raskova J, Raska K (1990) Soluble and cellular markers of immune activation in patients with systemic sclerosis. Clin Immunol Immunopathol 56:259–270PubMedCrossRef Degiannis D, Seibold JR, Czarnecki M, Raskova J, Raska K (1990) Soluble and cellular markers of immune activation in patients with systemic sclerosis. Clin Immunol Immunopathol 56:259–270PubMedCrossRef
96.
Zurück zum Zitat Kahan A, Kahan A, Picard F, Menkès CJ, Amor B (1991) Abnormalities of T lymphocyte subsets in systemic sclerosis demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. Ann Rheum Dis 50:354–358PubMedCentralPubMedCrossRef Kahan A, Kahan A, Picard F, Menkès CJ, Amor B (1991) Abnormalities of T lymphocyte subsets in systemic sclerosis demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. Ann Rheum Dis 50:354–358PubMedCentralPubMedCrossRef
97.
Zurück zum Zitat Dalkiliç E, Dilek K, Güllülü M, Yavuz M, Karakoç Y, Yurtkuran M, Budak F, Göral G (1999) Lymphocyte phenotypes in systemic sclerosis. Ann Rheum Dis 58:719–720PubMedCentralPubMedCrossRef Dalkiliç E, Dilek K, Güllülü M, Yavuz M, Karakoç Y, Yurtkuran M, Budak F, Göral G (1999) Lymphocyte phenotypes in systemic sclerosis. Ann Rheum Dis 58:719–720PubMedCentralPubMedCrossRef
98.
Zurück zum Zitat Koreck A, Surányi A, Szöny BJ, Farkas A, Bata-Csörgö Z, Kemény L, Dobozy A (2002) CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol 127:176–182PubMedCentralPubMedCrossRef Koreck A, Surányi A, Szöny BJ, Farkas A, Bata-Csörgö Z, Kemény L, Dobozy A (2002) CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol 127:176–182PubMedCentralPubMedCrossRef
100.
Zurück zum Zitat De Palma R, D’Aiuto E, Vettori S, Cuoppolo P, Abbate G, Valentini G (2010) Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role? Rheumatology 49:1257–1266. doi:10.1093/rheumatology/keq094 PubMedCrossRef De Palma R, D’Aiuto E, Vettori S, Cuoppolo P, Abbate G, Valentini G (2010) Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role? Rheumatology 49:1257–1266. doi:10.​1093/​rheumatology/​keq094 PubMedCrossRef
104.
Zurück zum Zitat Feghali CA, Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2:d12–d26PubMed Feghali CA, Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2:d12–d26PubMed
106.
Zurück zum Zitat Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S (2014) The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 48–49:50–52PubMedCrossRef Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S (2014) The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 48–49:50–52PubMedCrossRef
108.
Zurück zum Zitat Bhattacharyya S, Varga J (2015) Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis. Curr Rheumatol Rep 17(1):474PubMedCrossRef Bhattacharyya S, Varga J (2015) Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis. Curr Rheumatol Rep 17(1):474PubMedCrossRef
109.
Zurück zum Zitat Maverakis E, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y, Guiducci S, Hesselstrand R, Hummers LK, Duong C, Kahaleh B, Macgregor A, Matucci-Cerinic M, Wollheim FA, Mayes MD, Gershwin ME (2014) International consensus criteria for the diagnosis of Raynaud's phenomenon. J Autoimmun 48–49:60–65PubMedCrossRef Maverakis E, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y, Guiducci S, Hesselstrand R, Hummers LK, Duong C, Kahaleh B, Macgregor A, Matucci-Cerinic M, Wollheim FA, Mayes MD, Gershwin ME (2014) International consensus criteria for the diagnosis of Raynaud's phenomenon. J Autoimmun 48–49:60–65PubMedCrossRef
110.
Zurück zum Zitat van Bon L, Cossu M, Loof A, Gohar F, Wittkowski H, Vonk M, Roth J, van den Berg W, van Heerde W, Broen JC, Radstake TR (2014) Proteomic analysis of plasma identifies the toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype. Ann Rheum Dis 73(8):1585–1589PubMedCrossRef van Bon L, Cossu M, Loof A, Gohar F, Wittkowski H, Vonk M, Roth J, van den Berg W, van Heerde W, Broen JC, Radstake TR (2014) Proteomic analysis of plasma identifies the toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype. Ann Rheum Dis 73(8):1585–1589PubMedCrossRef
111.
Zurück zum Zitat Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, Bombardieri S (2014) The diagnosis and classification of mixed connective tissue disease. J Autoimmun 48–49:46–49PubMedCrossRef Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, Bombardieri S (2014) The diagnosis and classification of mixed connective tissue disease. J Autoimmun 48–49:46–49PubMedCrossRef
112.
Zurück zum Zitat Hudson M, Fritzler MJ (2014) Diagnostic criteria of systemic sclerosis. J Autoimmun 48–49:38–41PubMedCrossRef Hudson M, Fritzler MJ (2014) Diagnostic criteria of systemic sclerosis. J Autoimmun 48–49:38–41PubMedCrossRef
113.
Zurück zum Zitat Khor CG, Chen XL, Lin TS, Lu CH, Hsieh SC (2014) Rituximab for refractory digital infarcts and ulcers in systemic sclerosis. Clin Rheumatol 33(7):1019–1020PubMedCrossRef Khor CG, Chen XL, Lin TS, Lu CH, Hsieh SC (2014) Rituximab for refractory digital infarcts and ulcers in systemic sclerosis. Clin Rheumatol 33(7):1019–1020PubMedCrossRef
114.
Zurück zum Zitat Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161–167PubMedCrossRef Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161–167PubMedCrossRef
Metadaten
Titel
T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review
verfasst von
Isabel Almeida
Sara Vieira Silva
Ana Raquel Fonseca
Ivone Silva
Carlos Vasconcelos
Margarida Lima
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 3/2015
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-015-8505-8

Weitere Artikel der Ausgabe 3/2015

Clinical Reviews in Allergy & Immunology 3/2015 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.